Tired all the time? It may be this silent but serious health issue
Your enduring weariness could be a symptom of something more devastating.
In a study published this month in Neurology, researchers found a link between lingering fatigue and a transient ischemic attack (TIA), commonly known as a 'mini stroke.'
So how worried do you need to be?
3 TIA patients may suffer more long-term effects, including exhaustion.
Prostock-studio – stock.adobe.com
TIA is a temporary disruption of blood flow to the brain, spurring stroke-like symptoms that typically last two to 15 minutes.
People who have them are typically at higher risk of having a full-blown stroke in the near future.
And, as the new study suggests, TIA patients may actually suffer some more long-term effects, including exhaustion.
'People with a transient ischemic attack can have symptoms such as face drooping, arm weakness, or slurred speech, and these resolve within a day,' said study author Boris Modrau, MD, PhD, of Aalborg University Hospital in Denmark.
'However, some have reported continued challenges, including reduced quality of life, thinking problems, depression, anxiety, and fatigue. Our study found that for some people, fatigue was a common symptom that lasted up to one year after the transient ischemic attack.'
For this latest study, researchers followed patients who had experienced a mini-stroke for a year. The patient completed questionnaires to measure overall tiredness, physical tiredness, reduced activity, reduced motivation and mental fatigue.
3 Participants completed a detailed questionnaire to measure fatigue levels within two weeks of their stroke and again at three, six, and twelve months.
KMPZZZ – stock.adobe.com
'Long-term fatigue was common in our group of study participants, and we found that if people experience fatigue within two weeks after leaving the hospital, it is likely they will continue to have fatigue for up to a year,' said Modrau.
Previous experiences of anxiety and depression were twice as common in patients who reported lasting fatigue.
Participants also underwent brain scanning, wherein researchers found that blood clot presence was equal between participants who experienced long-term fatigue and those who did not.
The research team noted that one possible limitation of the study is that responses were self-reported, increasing the likelihood that responses were completed with assistance from, or influenced by, relatives and caretakers.
Experts maintain that mini-strokes are often a warning sign that a larger or more permanent stroke may develop in the near future, and experiencing a TIA could significantly increase the risk of developing cognitive decline and dementia.
3 Experiencing a TIA could significantly increase the risk of developing cognitive decline and dementia.
Proxima Studio – stock.adobe.com
'A stroke is when the neurological deficit lasts for more than a few hours and is more or less permanent,' Dr. Raphael Sacho, director of cerebrovascular and endovascular neurosurgery at Northwell Staten Island University Hospital, previously told The Post.
'A stroke is usually accompanied by evidence of stroke changes on imaging, such as an MRI scan of the brain, but often with a TIA, there are no or minimal signs of a stroke on brain imaging.'
The symptoms of a TIA include:
Weakness, numbness or paralysis in the face, arm or leg, often on one side of the body
Vision loss, blurred vision, double vision or difficulty seeing in one or both eyes
Trouble speaking, difficulty finding words or slurred speech
Dizziness, loss of balance or coordination
Confusion or trouble understanding others
Severe headache without a known cause
Difficulty walking, swallowing, reading or writing
Tingling in half the body
Experts agree that the prevention of strokes and mini-strokes is tied to improving overall cardiovascular health, such as blood pressure control, lowering cholesterol, and diabetes management.
The American Stroke Association (ASA) encourages adults to follow the Mediterranean diet no matter their stroke risk. The plant-based eating plan emphasizes fruits, vegetables, whole grains, and healthy fats, and not red meat and sugar.
The ASA, a division of the American Heart Association, also suggests cutting stroke risk by exercising regularly, getting sufficient sleep, maintaining a healthy weight, controlling cholesterol, managing blood pressure and blood sugar, and avoiding smoking.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
UT Health San Antonio researchers discover new links between heart disease and dementia
Research led by The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has discovered new associations between various lipid, or fat, levels in the blood and the risk of developing Alzheimer's disease. SAN ANTONIO, May 30, 2025 /PRNewswire-PRWeb/ -- People who are at higher risk for heart disease also seem more likely to develop dementia. And research led by The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has discovered new associations between various lipid, or fat, levels in the blood and the risk of developing Alzheimer's disease, the most common cause of dementia worldwide. The findings mean that using blood lipid profiles could help better understand, predict and possibly even prevent the disease in the future. In more than 800 older adults who were part of the long-running Framingham Heart Study, the researchers found that higher levels of small dense cholesterol particles – which are known to increase the risk of atherosclerosis and coronary heart disease – were associated with higher risk of developing Alzheimer's disease. However, higher levels of a marker for small fat-carrying particles, which are involved in the transport of dietary fats from the gut to other body tissues through the blood after eating, were associated with lower risk of developing the disease. Perhaps ironically, the researchers also discovered that individuals who had the lowest levels of highly dense cholesterol particles – often referred to as "good cholesterol" as it is considered protective against cardiovascular disease – had a lower risk of developing Alzheimer's disease compared to the rest of the included individuals. "These findings highlight the complex relationships of blood lipids with both heart and brain health, suggesting the possibility of certain blood lipids playing different roles in cardiovascular disease and dementia-related biological processes," said Sokratis Charisis, MD, a researcher with the Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases at UT Health San Antonio. Charisis is first author of the study published May 30 in the journal Neurology, titled, "Association of Blood Lipoprotein Levels With Incident Alzheimer's Disease in Community-Dwelling Individuals: The Framingham Heart Study." Other authors include corresponding author Sudha Seshadri, MD, director of the Biggs Institute, and researchers from Boston University School of Public Health, the University of Texas Rio Grande Valley and the Framingham Heart Study. A community-based analysis The new study notes that dementia is a leading source of morbidity and mortality in the aging population. Worldwide, there were 57.4 million people living with dementia in 2019, a number that is expected to reach 152.8 million by 2050. However, there is a general trend over time of decreasing incidence of Alzheimer's disease and other dementias in the U.S. and other higher-income countries that is at least partially attributed to better management of cardiovascular risk factors. The Framingham Heart Study is an ongoing, community-based cohort study that was launched in 1948 in Framingham, Massachusetts. Residents there ages 30 to 59 were randomly selected from census data to participate. Those with definite signs of cardiovascular disease at baseline were excluded. Participants of the original cohort have undergone up to 32 examinations performed every two years, which have included detailed history-taking by a physician, a physical examination and lab testing. The latest analysis by researchers led by UT Health San Antonio included participants from the original cohort who were 60 years or older and free of dementia during an examination period of 1985-1988, and had available cognitive follow-up and lipoprotein marker data. Lipoproteins act as a transport system for lipids in the bloodstream. Blood lipid levels and dementia Levels of high-density lipoprotein cholesterol (HDL-C), or good cholesterol; low-density lipoprotein cholesterol (LDL-C), or "bad cholesterol"; small dense LDL-C (sdLDL-C); and other lipoprotein types associated with heart disease were measured in blood samples obtained from the mid- to late-'80s examination period. The Framingham participants were watched for incident Alzheimer's disease, meaning a first diagnosis of the disease, until 2020. Of a total of 822 participants, 128 developed incident Alzheimer's disease. The researchers discovered that an increase of 1 standard deviation unit (SDU) of a concentration of small dense LDL-C (sdLDL-C), a value representing how far a specific data point deviates from the mean, was associated with a 21% increase in the risk for incident Alzheimer's disease. As the name implies, small dense LDL-C (sdLDL-C) is a type of the so-called bad cholesterol with smaller and denser particles than other low-density lipoproteins, and that is considered more likely to form plaque in arteries, strongly associated with an increased risk of atherosclerotic cardiovascular disease. A 1 SDU increase in a concentration of ApoB48, a lipoprotein that transports dietary fat from the intestines and into the bloodstream that also is tied to heart disease and cardiovascular problems, was found to be associated with a 22% decrease in the risk for incident Alzheimer's disease. Participants in the first quartile of HDL-C, or good cholesterol – in order of lesser amounts – were 44% less likely to develop Alzheimer's compared with those in the second, third and fourth quartiles. And those with small dense LDL-C concentrations below the median were 38% less likely to develop Alzheimer's compared with those with concentrations above the median. In summary, then, lower small-density bad cholesterol (sdLDL-C) concentrations and higher ApoB48 concentrations were associated with a lower Alzheimer's risk. And individuals with the lowest good cholesterol (HDL-C) concentrations were less likely to develop Alzheimer's compared with the remaining sample. "These findings underscore links between lipoprotein metabolism pathways and Alzheimer's risk, emphasizing the potential role of blood lipoprotein markers in Alzheimer's risk stratification and of lipid modification strategies in dementia prevention," the researchers concluded. Association of Blood Lipoprotein Levels With Incident Alzheimer's Disease in Community-Dwelling Individuals: The Framingham Heart Study Sokratis Charisis, Sophia Lu, Jesus David Melgarejo, Claudia L. Satizabal, Ramachandran S. Vasan, Alexa S. Beiser, Sudha Seshadri First published: May 30, 2025, in the journal Neurology Link to full study: The University of Texas Health Science Center at San Antonio (UT Health San Antonio), a primary driver of San Antonio's $44.1 billion health care and biosciences sector, is the largest academic research institution in South Texas with an annual research portfolio of more than $436 million. Driving substantial economic impact with its six professional schools, a diverse workforce of more than 9,400, an annual expense budget of $1.67 billion and clinical practices that provide 2.5 million patient visits each year, UT Health San Antonio plans continued growth over the next five years and anticipates adding more than 1,500 higher-wage jobs to serve San Antonio, Bexar County and the South Texas region. To learn about the many ways "We make lives better®," visit The Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases is dedicated to providing comprehensive dementia care while advancing treatment through clinical trials and research. The Biggs Institute is a National Institute on Aging (NIA)-designated Alzheimer's Disease Research Center (ADRC). In addition to patient care and research, the Biggs Institute partners with the School of Nursing at UT Health Science Center San Antonio to offer the Caring for the Caregiver program. Stay connected with The University of Texas Health Science Center at San Antonio on Facebook, Twitter, LinkedIn, Instagram and YouTube. Media Contact Steven Lee, 2104503823, lees22@ View original content: SOURCE
Medscape
3 days ago
- Medscape
When MS Meets Menopause: Is It Time to Rethink HRT?
PHOENIX — The overlapping symptoms of menopause and multiple sclerosis (MS) in aging women may warrant hormone replacement therapy (HRT), says one expert, who argues that the potential benefits in easing the combined symptom burden outweigh the therapy's modest risks. It is suspected but not proven that menopause increases the risk and severity of menopausal symptoms such as urinary dysfunction, vasomotor dysregulation, disturbed sleep, and anxiety, but it is known that HRT offers benefit against these, said Kate Petheram, MD, a consultant neurologist for the Royal Sunderland Hospital, Sunderland, UK. In women with MS, 'there is a clear benefit from controlling symptoms associated with menopause even if we do not know yet whether the benefit involves reducing symptoms driven by MS,' Petheram reported. The modest amount of attention paid to the overlap between symptoms of MS and menopause is an important issue for a disease with a 3:1 female to male ratio, said Petheram, in a May 29 presentation at the Consortium of Multiple Sclerosis Centers (CMSC) 2025 Annual Meeting. WHI: Flawed Data Speaking at a symposium dedicated to the topic, Petheram noted that her audience was almost entirely female: a pattern she has observed in previous iterations of the same talk. She urged all neurologists to recognize the interplay between menopause and MS, emphasizing that 30% of people with MS are peri- or postmenopausal women. In the UK, as in the US, prescriptions for HRT plummeted following the 2002 publication of the Women's Health Initiative (WHI): a study involving more than 16,000 participants that was halted after 5.2 years of follow-up. At the time, a widely used combination of conjugated equine estrogen and medroxyprogesterone was linked to several risks — including breast cancer, cardiovascular disease, and stroke — that were deemed to outweigh its symptomatic benefits. Subsequent data have refuted most of those claims, said Petheram, who described the WHI study design as flawed. In fact, current evidence suggests HRT lowers cardiovascular risk. While it does increase the risk of breast cancer, she noted that the increase is modest — and importantly, the risk of dying from breast cancer is not significantly elevated. Yet the reexamination of the evidence has never received the attention needed to shift perceptions shaped by the original WHI study, said Petheram. She described a 'loss of confidence' in HRT that has been only modestly reversed in the UK and not at all in the US. Drawing on published data, she noted that HRT use among menopausal women remains below 5% in the US, compared to 15% in the UK. This poses a particular challenge for women with MS, given the overlap between menopausal symptoms and MS-related complaints. While some issues — such as anxiety and sleep disturbances — may be managed with other therapies, HRT remains one of the most effective treatments for vasomotor symptoms, sexual dysfunction, and urinary complaints. An Effective Option Both historical and emerging evidence suggest that HRT can reduce symptoms shared by MS and menopause, Petheram said. In the observational Nurses' Health Study — a 2016 analysis published in Neurology , for example — women with MS who began HRT 3-10 years after their final menstrual period showed significant improvements across multiple validated quality-of-life measures compared to those who did not use HRT. 'Menopausal women do well on HRT, and they do less well when they quit,' said Petheram, citing multiple studies, including several published in recent years. While she acknowledged that HRT is not a panacea, she emphasized that it remains the only therapy that effectively targets the wide range of symptoms common to both MS and menopause. The ability to address a wide range of symptoms is a significant advantage. Citing fatigue, mood disorders, and sexual and urinary issues as the most common overlapping complaints, Petheram noted that HRT offers additional documented benefits — such as improved bone health — that are meaningful not only to aging women in general, but especially to those with MS. This message is starting to gain traction in the UK, but Jennifer Graves, MD, PhD, director of the Neuroimmunology Research Program at the University of California, San Diego, acknowledged that it will be a tougher sell in the US without targeted education to overcome longstanding biases. 'The WHI is still being taught in some medical schools,' she said. While she agreed that some of the most serious risks linked to HRT in the WHI have since been rescinded — warranting a reassessment of the benefit-to-risk ratio — she also emphasized that aging and menopause in women with MS remain largely overlooked. 'We need greater awareness of the challenges of menopause in women with MS and I think this involves better educating clinicians about how aging, menopause, and MS intersect,' Graves said. Petheram clarified that she doesn't prescribe HRT to women with MS, but she does discuss the overlap between menopausal and MS symptoms — explaining both the potential benefits and risks to help patients make informed decisions. She believes all neurologists should take responsibility for understanding the interaction between menopause and MS in order to better manage overlapping symptoms.
Yahoo
3 days ago
- Yahoo
Thanks to those who won't keep their mouths shut
(Photo by Prostock-Studio/Getty Images) Our admiration goes to the Davids of the world: those who stand up, speak out and fight back, refusing to let the Goliaths intimidate or silence them. A recent example is a story by Clark Kauffman, reporter at the Iowa Capital Dispatch. He detailed the allegations in a lawsuit filed by a former certified nurse aide at a nursing home in Fonda, Iowa. The suit was filed against the Fonda Specialty Care nursing home, its parent company, Care Initiatives, and a licensed practical nurse working at the facility. You can read the April 30 story here. The suit alleges that a certified nurse aide observed an 87-year-old resident with a tracheostomy struggling to breathe. The aide sought help from the on-duty nurse to suction the resident's airway. The nurse refused to intervene despite multiple requests from staff members. The aide attempted to contact off-site management but could reach no one. She asked for permission to call 911 and was rebuffed. The resident ultimately died in a manner the lawsuit describes as 'agonizing and painful.' The suit also claims that after the certified nurse aide finished her shift, she received multiple text messages from the facility's administrator to 'keep your mouth shut and keep your opinions to yourself.' She was also instructed not to communicate with the family of the resident who died. The next day, the aide was fired. The facility cited 'resident complaints' as the reason. The nurse aide said she was fired for reporting the incident to the state. KTIV television in Sioux City posted Kauffman's article on their Facebook page, drawing nearly 600 reactions and 200 comments. Responses were candid and often angry. A small sample includes: 'I would never put my parents or anybody I know in a nursing home.' 'The fact that the nursing home tried to cover it up is just as horrible' (as the death). 'My heart breaks for the family and the aides that witnessed it.' 'This makes me sick.' This makes us sick, too. How about you? Imagine being in the shoes of the staff member who allegedly tried to do the right thing, witnessed a horrible death, was fired by her employer, and then had to decide 'what's next?' This nurse's aide chose not 'to keep her mouth shut' but instead to challenge a powerful corporation in court. Some would say that's a fool's errand. We view it as an admirable act of courage. Put this in a larger context. We live in a time where many people, including elected officials, organizations and businesses, find themselves in situations similar to the nurse aide where they are expected to do what they are told and avoid speaking out or acting on what they believe is right. Here are recent examples: Legislators who don't vote the way a governor or president demands. The student on campus who speaks up for Palestinians. The university president or corporate head who doesn't comply with diversity, equity and inclusion directives. National news organizations that write an editorial or airs programs the powers that be don't like. Foreign leaders who disagree publicly with a U.S. government representative. Law firms that challenge governmental actions. Entertainers who bring attention to social injustices. The list could go on and on. It's not a good time to be an independent thinker, to swim against the tide, or to tell the emperor that they have no clothes. The message to all the rulebreakers out there is this: Toe the line. Do what you're told. There will be hell to pay if you disobey. The fact that it's not a good time to speak out is why we need people to speak out. We applaud the certified nurse aide and all those like her who are courageously standing up for what they believe. They are making what John Lewis called 'good trouble.' Davids can and do defeat the Goliaths. Not all the time, not without great difficulty. But is the fight worth fighting? Indeed, it is. John and Terri Hale own The Hale Group, an Ankeny-based advocacy firm focused on older Iowans, Iowans with disabilities and the caregivers who support them. Contact them at terriandjohnhale@
